Neurofibromatosis Clinical Trials Neurofibromatosis RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Clinical Trial to Evaluate the Safety and Efficacy of AL2846 Capsules in Chinese Patients With Type I Neurofibromatosis
Condition:   Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors Intervention:   Drug: AL2846 capsules Sponsor:   Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 18, 2021 Category: Research Source Type: clinical trials

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)
Conditions:   Cutaneous Neurofibroma;   Neurofibromatosis 1 Interventions:   Drug: NFX-179 gel;   Drug: Vehicle gel Sponsor:   NFlection Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2021 Category: Research Source Type: clinical trials